NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125 | +11.6% | 17,307 | +14.6% | 0.00% | – |
| Q2 2023 | $112 | +21.7% | 15,106 | +13.6% | 0.00% | – |
| Q1 2023 | $92 | -32.4% | 13,297 | -0.1% | 0.00% | – |
| Q4 2022 | $136 | -99.9% | 13,312 | +15.7% | 0.00% | -100.0% |
| Q3 2022 | $209,000 | -69.2% | 11,508 | -12.9% | 0.00% | -50.0% |
| Q2 2022 | $679,000 | -17.4% | 13,211 | +18.4% | 0.00% | 0.0% |
| Q1 2022 | $822,000 | -55.0% | 11,161 | -12.6% | 0.00% | -50.0% |
| Q4 2021 | $1,826,000 | -30.0% | 12,764 | +1.4% | 0.00% | -42.9% |
| Q3 2021 | $2,610,000 | +24.9% | 12,593 | +27.9% | 0.01% | +40.0% |
| Q2 2021 | $2,090,000 | +19.7% | 9,847 | +2.2% | 0.01% | 0.0% |
| Q1 2021 | $1,746,000 | +22.9% | 9,634 | -24.4% | 0.01% | +25.0% |
| Q4 2020 | $1,421,000 | -15.1% | 12,751 | -17.5% | 0.00% | -33.3% |
| Q3 2020 | $1,674,000 | +103.4% | 15,454 | +56.5% | 0.01% | +100.0% |
| Q2 2020 | $823,000 | +315.7% | 9,877 | -32.3% | 0.00% | +200.0% |
| Q1 2020 | $198,000 | +273.6% | 14,587 | +9.3% | 0.00% | – |
| Q4 2019 | $53,000 | – | 13,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |